GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

The World Health Organization listed KM Biologics' mpox vaccine for emergency use on Tuesday, making it the second shot to ...

The listing from the World Health Organization paves the way for countries worldwide to quickly approve and import the ...

The World Health Organization has permitted emergency use of a Japanese vaccine to inoculate against mpox, previously known ...

The World Health Organisation (WHO) has granted emergency use listing (EUL) for the LC16m8 mpox vaccine. This would be the ...

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of Arexvy (respiratory syncytial virus vaccine, recombinant ...

Nov 22 (Reuters) - GSK (GSK.L), opens new tab said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in adults aged between 50 and 59 ...

The Government of Japan will donate 3.05 million doses of the vaccine, along with certain specialized needles, to Congo, the WHO said. The vaccine has been used in Japan during previous mpox ...

The World Health Organization has granted emergency use of a Japanese mpox vaccine, its second approval of a product to inoculate against the infectious disease, to combat a recent outbreak mainly in ...

In September, after facing criticism for moving too slowly on vaccines, the agency cleared Bavarian Nordic's vaccine for mpox and said it was considering LC16, made by Japan's KM Biologics ...